URL has been copied successfully!

URL has been copied successfully!

RBC Capital Lifts PT BioCryst Pharmaceuticals (BCRX) as Part of Q1 2026 Results Preview in Biotech

On: May 2, 2026

URL has been copied successfully!

Please follow us:

This post was originally published here

Previous Post:Kiniksa Pharmaceuticals International (KNSA) Announces Q1 2026 Financial Results

Next Post:Neurocrine Biosciences (NBIX) Announces First Presentation of New Two-Year Data From Phase 3 CAHtalyst® Adult Study